{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:09:27Z","timestamp":1780492167606,"version":"3.54.1"},"reference-count":262,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.peptides.2024.171166","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T19:06:21Z","timestamp":1706814381000},"page":"171166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Therapeutic potential of vasopressin in the treatment of neurological disorders"],"prefix":"10.1016","volume":"174","author":[{"given":"Shweta","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranay","family":"Wal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauri U.","family":"Bhivshet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpan Kumar","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Walia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1385\/JMN:18:3:223","article-title":"Dynamic processing of neuropeptides: sequential conformation shaping of neurohypophysial preprohormones during intraneuronal secretory transport","volume":"18","author":"Acher","year":"2002","journal-title":"J. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/2229-516X.106347","article-title":"Vaptans: A new option in the management of hyponatremia","volume":"2","author":"Aditya","year":"2012","journal-title":"Int J. Appl. Basic Med Res"},{"issue":"1-2","key":"10.1016\/j.peptides.2024.171166_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-0115(00)00196-8","article-title":"Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation","volume":"96","author":"Aguilera","year":"2000","journal-title":"Regul. Pept."},{"key":"10.1016\/j.peptides.2024.171166_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yfrne.2014.07.001","article-title":"Species, sex and individual differences in the vasotocin\/vasopressin system: relationship to neurochemical signaling in the social behavior neural network","volume":"36","author":"Albers","year":"2015","journal-title":"Front Neuroendocr."},{"issue":"7","key":"10.1016\/j.peptides.2024.171166_bib5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/00001756-200205240-00006","article-title":"Serotonin and vasopressin interact in the hypothalamus to control communicative behavior","volume":"13","author":"Albers","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.peptides.2024.171166_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0079-6123(08)61590-3","article-title":"Role of vasopressin in learning and memory in the hippocampus","volume":"119","author":"Alescio-Lautier","year":"1998","journal-title":"Prog. Brain Res"},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2165\/00003495-200767060-00002","article-title":"Therapeutic potential of vasopressin receptor antagonists","volume":"67","author":"Ali","year":"2007","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.peptides.2024.171166_bib8","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nrn1252","article-title":"The molecular basis of water transport in the brain","volume":"4","author":"Amiry-Moghaddam","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.peptides.2024.171166_bib9","series-title":"The Rat Nervous System","first-page":"295","article-title":"Hypothalamic supraoptic and paraventricular nuclei","author":"Armstrong","year":"2015"},{"key":"10.1016\/j.peptides.2024.171166_bib10","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3389\/fnins.2015.00510","article-title":"Oxytocin and Vasopressin Receptor Gene Polymorphisms: Role in Social and Psychiatric Traits","volume":"9","author":"Asp\u00e9-S\u00e1nchez","year":"2016","journal-title":"Front Neurosci."},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1358\/mf.2003.25.3.769639","article-title":"Effects of [Arg8]-vasopressin on regional cerebral blood flow in spontaneously hypertensive rats","volume":"25","author":"Azuma","year":"2003","journal-title":"Methods Find. Exp. Clin. Pharm."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00004647-200204000-00001","article-title":"Aquaporins in brain: distribution, physiology, and pathophysiology","volume":"22","author":"Badaut","year":"2002","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0306-4522(03)00425-1","article-title":"Activation of voltage-sensitive sodium channels during oxygen deprivation leads to apoptotic neuronal death","volume":"126","author":"Banasiak","year":"2004","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/joim.12645","article-title":"Vasopressin: physiology, assessment and osmosensation","volume":"282","author":"Bankir","year":"2017","journal-title":"J. Intern Med"},{"issue":"12","key":"10.1016\/j.peptides.2024.171166_bib15","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1523\/JNEUROSCI.23-12-05061.2003","article-title":"Na-K-Cl cotransporter contributes to glutamate-mediated excitotoxicity","volume":"23","author":"Beck","year":"2003","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0022-3476(78)80389-8","article-title":"1-deamino-8-D-arginine vasopressin in the treatment of central diabetes insipidus in childhood","volume":"92","author":"Becker","year":"1978","journal-title":"J. Pedia"},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/nau.23830","article-title":"Aging increases the expression of vasopressin receptors in both the kidney and urinary bladder","volume":"38","author":"Birder","year":"2019","journal-title":"Neurourol. Urodyn."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1476-5381.1979.tb08704.x","article-title":"Hydroxy analogues of oxytocin and of lysine-vasopressin","volume":"67","author":"Bisset","year":"1979","journal-title":"Br. J. Pharm."},{"issue":"3 Pt 1","key":"10.1016\/j.peptides.2024.171166_bib19","first-page":"E295","article-title":"Vasopressin regulates human sleep by reducing rapid-eye-movement sleep","volume":"262","author":"Born","year":"1992","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12987-019-0129-6","article-title":"Cerebrospinal fluid dynamics and intracranial pressure elevation in neurological diseases","volume":"16","author":"Bothwell","year":"2019","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.peptides.2024.171166_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev.physiol.59.1.601","article-title":"Osmoreceptors in the central nervous system","volume":"59","author":"Bourque","year":"1997","journal-title":"Annu Rev. Physiol."},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib22","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1590\/S0066-782X2012005000062","article-title":"Felypressin increases blood pressure during dental procedures in hypertensive patients","volume":"99","author":"Bronzo","year":"2012","journal-title":"Arq. Bras. Cardiol."},{"issue":"8","key":"10.1016\/j.peptides.2024.171166_bib23","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/jne.12051","article-title":"Physiological regulation of magnocellular neurosecretory cell activity: integration of intrinsic, local and afferent mechanisms","volume":"25","author":"Brown","year":"2013","journal-title":"J. Neuroendocr."},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib24","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1152\/physrev.2001.81.3.1197","article-title":"Gene regulation in the magnocellular hypothalamo-neurohypophysial system","volume":"81","author":"Burbach","year":"2001","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2007.10.007","article-title":"Vasopressin: behavioral roles of an \"original\" neuropeptide","volume":"84","author":"Caldwell","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.peptides.2024.171166_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2017.00567","article-title":"Social Context, Stress, Neuropsychiatric Disorders, and the Vasopressin 1b Receptor","volume":"11","author":"Caldwell","year":"2017","journal-title":"Front Neurosci."},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1021\/jm00122a017","article-title":"Structure-activity relationships of novel vasopressin antagonists containing C-terminal diaminoalkanes and (aminoalkyl)guanidines","volume":"32","author":"Callahan","year":"1989","journal-title":"J. Med Chem."},{"key":"10.1016\/j.peptides.2024.171166_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mcn.2014.04.005","article-title":"Temporal alterations in aquaporin and transcription factor HIF1\u03b1 expression following penetrating ballistic-like brain injury (PBBI)","volume":"60","author":"Cartagena","year":"2014","journal-title":"Mol. Cell Neurosci."},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib29","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2344\/0003-3006(2006)53[119:CEOF]2.0.CO;2","article-title":"Cardiovascular effects of felypressin","volume":"53","author":"Cecanho","year":"2006","journal-title":"Anesth. Prog."},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/ijnp\/pyab013","article-title":"Vasopressin V1B Receptor Antagonists as Potential Antidepressants","volume":"24","author":"Chaki","year":"2021","journal-title":"Int J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1179\/016164105X25243","article-title":"The role of Na-K-Cl co-transporter in cerebral ischemia","volume":"27","author":"Chen","year":"2005","journal-title":"Neurol. Res"},{"issue":"17","key":"10.1016\/j.peptides.2024.171166_bib34","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1523\/JNEUROSCI.21-17-06512.2001","article-title":"Cell swelling and a nonselective cation channel regulated by internal Ca2+ and ATP in native reactive astrocytes from adult rat brain","volume":"21","author":"Chen","year":"2001","journal-title":"J. Neurosci."},{"issue":"24","key":"10.1016\/j.peptides.2024.171166_bib35","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.1523\/JNEUROSCI.23-24-08568.2003","article-title":"Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain","volume":"23","author":"Chen","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.peptides.2024.171166_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.716825","article-title":"Cerebral Edema Formation After Stroke: Emphasis on Blood-Brain Barrier and the Lymphatic Drainage System of the Brain","volume":"15","author":"Chen","year":"2021","journal-title":"Front Cell Neurosci."},{"issue":"1-2","key":"10.1016\/j.peptides.2024.171166_bib37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0006-8993(95)01006-7","article-title":"Long-lasting enhancement of synaptic excitability of CA1\/subiculum neurons of the rat ventral hippocampus by vasopressin and vasopressin(4-8)","volume":"701","author":"Chepkova","year":"1995","journal-title":"Brain Res"},{"issue":"11","key":"10.1016\/j.peptides.2024.171166_bib38","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.tips.2017.08.005","article-title":"The Action Radius of Oxytocin Release in the Mammalian CNS: From Single Vesicles to Behavior","volume":"38","author":"Chini","year":"2017","journal-title":"Trends Pharm. Sci."},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib39","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1159\/000126185","article-title":"Hypoglycemia-induced arginine vasopressin and oxytocin release is mediated by glucoreceptors located inside the blood-brain barrier","volume":"55","author":"Chiodera","year":"1992","journal-title":"Neuroendocrinology"},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ecl.2013.02.005","article-title":"Age-associated abnormalities of water homeostasis","volume":"42","author":"Cowen","year":"2013","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.peptides.2024.171166_bib41","series-title":"Vasopressin","article-title":"Physiology","author":"Cuzzo","year":"2023"},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib42","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/00000539-200006000-00008","article-title":"Ornipressin (Por 8): An efficient alternative to counteract hypotension during combined general\/epidural anesthesia","volume":"90","author":"De Kock","year":"2000","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.peptides.2024.171166_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6123(08)61558-7","article-title":"Anatomy and function of extrahypothalamic vasopressin systems in the brain","volume":"119","author":"de Vries","year":"1998","journal-title":"Prog. Brain Res"},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/jth.13576","article-title":"Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Desborough","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/ijms21010183","article-title":"Lixivaptan, a New Generation Diuretic, Counteracts Vasopressin-Induced Aquaporin-2 Trafficking and Function in Renal Collecting Duct Cells","volume":"21","author":"Di Mise","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0166-4328(97)02278-X","article-title":"Vasopressin and memory. II. Lesions to the hippocampus block the memory enhancing effects of AVP4-9 in the radial maze","volume":"87","author":"Dietrich","year":"1997","journal-title":"Behav. Brain Res"},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1469-7580.2005.00443.x","article-title":"Anatomy of melancholia: focus on hypothalamic-pituitary-adrenal axis overactivity and the role of vasopressin","volume":"207","author":"Dinan","year":"2005","journal-title":"J. Anat."},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/WCO.0b013e328337f451","article-title":"Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments","volume":"23","author":"Donkin","year":"2010","journal-title":"Curr. Opin. Neurol."},{"issue":"5","key":"10.1016\/j.peptides.2024.171166_bib49","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1113\/jphysiol.2015.284471","article-title":"Large conductance Ca\u00b2\u207a-activated K\u207a (BK) channels promote secretagogue-induced transition from spiking to bursting in murine anterior pituitary corticotrophs","volume":"593","author":"Duncan","year":"2015","journal-title":"J. Physiol."},{"issue":"12","key":"10.1016\/j.peptides.2024.171166_bib50","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1172\/JCI107521","article-title":"The role of blood osmolality and volume in regulating vasopressin secretion in the rat","volume":"52","author":"Dunn","year":"1973","journal-title":"J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1750-3639.2004.tb00072.x","article-title":"Chronic hydrocephalus in adults","volume":"14","author":"Edwards","year":"2004","journal-title":"Brain Pathol."},{"issue":"2 Pt 2","key":"10.1016\/j.peptides.2024.171166_bib52","first-page":"R376","article-title":"Vasopressin and fetal cerebrovascular regulation","volume":"263","author":"Eisenach","year":"1992","journal-title":"Am. J. Physiol."},{"issue":"3-4","key":"10.1016\/j.peptides.2024.171166_bib53","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.yfrne.2004.09.001","article-title":"The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited","volume":"25","author":"Engelmann","year":"2004","journal-title":"Front Neuroendocr."},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00394-017-1595-8","article-title":"Effects of hydration on plasma copeptin, glycemia and gluco-regulatory hormones: a water intervention in humans","volume":"58","author":"Enh\u00f6rning","year":"2019","journal-title":"Eur. J. Nutr."},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib55","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/joim.13489","article-title":"Seasonal variation of vasopressin and its relevance for the winter peak of cardiometabolic disease: A pooled analysis of five cohorts","volume":"292","author":"Enh\u00f6rning","year":"2022","journal-title":"J. Intern Med"},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib56","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/nau.23939","article-title":"International Continence Society consensus on the diagnosis and treatment of nocturia","volume":"38","author":"Everaert","year":"2019","journal-title":"Neurourol. Urodyn."},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib57","doi-asserted-by":"crossref","DOI":"10.1117\/1.NPh.3.3.031411","article-title":"Cerebral blood flow and autoregulation: current measurement techniques and prospects for noninvasive optical methods","volume":"3","author":"Fantini","year":"2016","journal-title":"Neurophotonics"},{"issue":"6 Pt 2","key":"10.1016\/j.peptides.2024.171166_bib58","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/01.HYP.17.6.917","article-title":"Regulation of cerebral blood vessels by humoral and endothelium-dependent mechanisms. Update on humoral regulation of vascular tone","volume":"17","author":"Faraci","year":"1991","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib59","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/01.RES.63.2.373","article-title":"Humoral regulation of blood flow to choroid plexus: role of arginine vasopressin","volume":"63","author":"Faraci","year":"1988","journal-title":"Circ. Res"},{"issue":"8","key":"10.1016\/j.peptides.2024.171166_bib60","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/sj.bjp.0704034","article-title":"Cerebral vasoconstriction produced by vasopressin in conscious goats: role of vasopressin V(1) and V(2) receptors and nitric oxide","volume":"132","author":"Fern\u00e1ndez","year":"2001","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.peptides.2024.171166_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2022.105750","article-title":"Developmental exposure to intranasal vasopressin impacts adult prairie vole spatial memory","volume":"141","author":"Finton","year":"2022","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0006-8993(85)91351-4","article-title":"The vasopressin and oxytocin neurons in the human supraoptic and paraventricular nucleus; changes with aging and in senile dementia","volume":"342","author":"Fliers","year":"1985","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2024.171166_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.00430","article-title":"Glial Cells Are Involved in ANG-II-Induced Vasopressin Release and Sodium Intake in Awake Rats","volume":"9","author":"Fl\u00f4r","year":"2018","journal-title":"Front Physiol."},{"key":"10.1016\/j.peptides.2024.171166_bib64","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.brainres.2014.01.021","article-title":"Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders","volume":"1580","author":"Francis","year":"2014","journal-title":"Brain Res"},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib65","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1177\/1756287213502116","article-title":"Desmopressin in the treatment of nocturia: clinical evidence and experience","volume":"5","author":"Friedman","year":"2013","journal-title":"Ther. Adv. Urol."},{"issue":"1-2","key":"10.1016\/j.peptides.2024.171166_bib66","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0166-4328(97)86051-2","article-title":"Effect of active fragments of arginine-vasopressin on the disturbance of spatial cognition in rats","volume":"83","author":"Fujiwara","year":"1997","journal-title":"Behav. Brain Res"},{"issue":"10","key":"10.1016\/j.peptides.2024.171166_bib67","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1681\/ASN.2005040371","article-title":"Molecular biology of hereditary diabetes insipidus","volume":"16","author":"Fujiwara","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.peptides.2024.171166_bib68","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/jnnp.50.7.929","article-title":"Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia","volume":"50","author":"Fujiyoshi","year":"1987","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1-3","key":"10.1016\/j.peptides.2024.171166_bib69","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.regpep.2004.12.009","article-title":"Serotonin-induced enhancement of vasopressin and oxytocin secretion in rat neurohypophyseal tissue culture","volume":"127","author":"G\u00e1lfi","year":"2005","journal-title":"Regul. Pept."},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib70","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12028-011-9525-8","article-title":"Open-label randomized trial of the safety and efficacy of a single dose conivaptan to raise serum sodium in patients with traumatic brain injury","volume":"14","author":"Galton","year":"2011","journal-title":"Neurocrit Care"},{"issue":"5","key":"10.1016\/j.peptides.2024.171166_bib71","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/apt.13912","article-title":"Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1","volume":"45","author":"Gifford","year":"2017","journal-title":"Aliment Pharm. Ther."},{"issue":"7622","key":"10.1016\/j.peptides.2024.171166_bib72","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature19756","article-title":"Clock-driven vasopressin neurotransmission mediates anticipatory thirst prior to sleep","volume":"537","author":"Gizowski","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2024.171166_bib73","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12577","article-title":"Activation of organum vasculosum neurons and water intake in mice by vasopressin neurons in the suprachiasmatic nucleus.","author":"Gizowski","year":"2018","journal-title":"J. Neuroendocr."},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib74","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.3390\/ijms23063068","article-title":"Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides","volume":"23","author":"Glava\u0161","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.peptides.2024.171166_bib75","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fendo.2013.00026","article-title":"Stress responsiveness of the hypothalamic-pituitary-adrenal axis: age-related features of the vasopressinergic regulation","volume":"4","author":"Goncharova","year":"2013","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"12","key":"10.1016\/j.peptides.2024.171166_bib76","first-page":"1347","article-title":"The investigation of vasopressin secretion in normal condition and during seizure onset in krushinsky-molodkina rats","volume":"101","author":"Gorbacheva","year":"2015","journal-title":"Ross. Fiziol. Zh. . Im. I M Sechenova"},{"key":"10.1016\/j.peptides.2024.171166_bib77","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.psyneuen.2018.05.031","article-title":"Oxytocin and brain activity in humans: A systematic review and coordinate-based meta-analysis of functional MRI studies","volume":"96","author":"Grace","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib78","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0006-8993(91)90369-7","article-title":"Amygdala kindling elevates plasma vasopressin","volume":"538","author":"Greenwood","year":"1991","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib79","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0304-3940(97)13455-3","article-title":"Persistent elevation of corticotrophin releasing factor and vasopressin but not oxytocin mRNA in the rat after kindled seizures","volume":"224","author":"Greenwood","year":"1997","journal-title":"Neurosci. Lett."},{"issue":"1-2","key":"10.1016\/j.peptides.2024.171166_bib80","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0169-328X(94)90101-5","article-title":"Vasopressin mRNA changes during kindling: the effects of kindling site and stage","volume":"26","author":"Greenwood","year":"1994","journal-title":"Brain Res Mol. Brain Res"},{"issue":"16","key":"10.1016\/j.peptides.2024.171166_bib81","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1097\/00001756-200211150-00011","article-title":"Arginine vasopressin in the pathogenesis of febrile convulsion and temporal lobe epilepsy","volume":"13","author":"Gulec","year":"2002","journal-title":"Neuroreport"},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib82","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.npep.2005.09.002","article-title":"Arginine vasopressin does not contribute to seizures induced by intracerebroventricularly-injected pilocarpine","volume":"39","author":"Gulec","year":"2005","journal-title":"Neuropeptides"},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib83","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40520-013-0064-3","article-title":"Generalized tonic-clonic seizures in adult patients following intravenous administration of desmopressin","volume":"25","author":"Guo","year":"2013","journal-title":"Aging Clin. Exp. Res"},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0196-9781(85)90070-1","article-title":"The effect of chronic vs. acute injection of vasopressin on animal learning and memory","volume":"6","author":"Hamburger-Bar","year":"1985","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib85","first-page":"211","article-title":"Vasopressin in the cerebrospinal fluid of patients with normal pressure hydrocephalus and benign intracranial hypertension","volume":"100","author":"Hammer","year":"1982","journal-title":"Acta Endocrinol. (Copenh)"},{"issue":"11","key":"10.1016\/j.peptides.2024.171166_bib86","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/jne.12325","article-title":"Localisation of 11\u03b2-Hydroxysteroid Dehydrogenase Type 2 in Mineralocorticoid Receptor Expressing Magnocellular Neurosecretory Neurones of the Rat Supraoptic and Paraventricular Nuclei","volume":"27","author":"Haque","year":"2015","journal-title":"J. Neuroendocr."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib87","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12846","article-title":"Audiogenic kindling activates expression of vasopressin in the hypothalamus of Krushinsky-Molodkina rats genetically prone to reflex epilepsy","volume":"32","author":"Harbachova","year":"2020","journal-title":"J. Neuroendocr."},{"key":"10.1016\/j.peptides.2024.171166_bib88","series-title":"EAU guidelines on management of non-neurogenic female lower urinary tract symptoms","author":"Harding","year":"2022"},{"key":"10.1016\/j.peptides.2024.171166_bib89","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-014-0213-0","article-title":"Treatment of stroke related refractory brain edema using mixed vasopressin antagonism: a case report and review of the literature","volume":"14","author":"Hedna","year":"2014","journal-title":"BMC Neurol."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib90","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1210\/endo.142.4.8067","article-title":"Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin","volume":"142","author":"Hernando","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2024.171166_bib91","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00134-015-3771-8","article-title":"What\u2019s new on the HPA axis?","volume":"41","author":"Hofland","year":"2015","journal-title":"Intensive Care Med."},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib92","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0197-4580(95)02016-0","article-title":"Influence of aging on the seasonal rhythm of the vasopressin-expressing neurons in the human suprachiasmatic nucleus","volume":"16","author":"Hofman","year":"1995","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib93","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/j.jvca.2009.09.006","article-title":"Vasopressin: a review of therapeutic applications","volume":"24","author":"Holt","year":"2010","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib94","doi-asserted-by":"crossref","first-page":"p46","DOI":"10.1159\/000119709","article-title":"Hyponatremia revisited: translating physiology to practice","volume":"108","author":"Hoorn","year":"2008","journal-title":"Nephron Physiol."},{"key":"10.1016\/j.peptides.2024.171166_bib95","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev.pa.30.040190.002441","article-title":"Conformational and structural considerations in oxytocin-receptor binding and biological activity","volume":"30","author":"Hruby","year":"1990","journal-title":"Annu Rev. Pharm. Toxicol."},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib96","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1631\/jzus.2005.B0033","article-title":"Increased expression of aquaporin-4 in human traumatic brain injury and brain tumors","volume":"6","author":"Hu","year":"2005","journal-title":"J. Zhejiang Univ. Sci. B"},{"issue":"5719","key":"10.1016\/j.peptides.2024.171166_bib97","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.1105636","article-title":"Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala","volume":"308","author":"Huber","year":"2005","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib98","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/18715303113136660042","article-title":"Role of central and peripheral chemoreceptors in vasopressin secretion control","volume":"13","author":"Iovino","year":"2013","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib99","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2826.1999.00318.x","article-title":"Activity of vasopressinergic neurones of the human supraoptic nucleus is age- and sex-dependent","volume":"11","author":"Ishunina","year":"1999","journal-title":"J. Neuroendocr."},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jphs.13R13CP","article-title":"Therapeutic potential of vasopressin-receptor antagonists in heart failure","volume":"124","author":"Izumi","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib101","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0006-8993(00)03050-X","article-title":"Daily profiles of arginine vasopressin mRNA in the suprachiasmatic, supraoptic and paraventricular nuclei of the rat hypothalamus under various photoperiods","volume":"887","author":"J\u00e1c","year":"2000","journal-title":"Brain Res"},{"issue":"Pt 12","key":"10.1016\/j.peptides.2024.171166_bib102","first-page":"2302","article-title":"The effect of vasopressin 1b receptor (V1bR) blockade on HPA axis activity in rats exposed to acute heat stress","volume":"216","author":"Jasnic","year":"2013","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.peptides.2024.171166_bib103","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.eplepsyres.2016.07.006","article-title":"The modulatory effect of nitric oxide in pro- and anti-convulsive effects of vasopressin in PTZ-induced seizures threshold in mice","volume":"126","author":"Javadian","year":"2016","journal-title":"Epilepsy Res"},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib104","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neulet.2008.11.053","article-title":"Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo","volume":"450","author":"Jing","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib105","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1532-5415.1994.tb07488.x","article-title":"Arginine vasopressin and osmolality in the elderly","volume":"42","author":"Johnson","year":"1994","journal-title":"J. Am. Geriatr. Soc."},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib106","doi-asserted-by":"crossref","first-page":"F1318","DOI":"10.1152\/ajprenal.00485.2016","article-title":"Molecular mechanisms regulating aquaporin-2 in kidney collecting duct","volume":"311","author":"Jung","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.peptides.2024.171166_bib107","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/neu.1996.13.273","article-title":"Arginine vasopressin receptor antagonists for treatment of vasogenic brain edema: an experimental study","volume":"13","author":"Kagawa","year":"1996","journal-title":"J. Neurotrauma"},{"issue":"5","key":"10.1016\/j.peptides.2024.171166_bib108","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2826.2010.01956.x","article-title":"Vasopressin and the output of the hypothalamic biological clock","volume":"22","author":"Kalsbeek","year":"2010","journal-title":"J. Neuroendocr."},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib109","doi-asserted-by":"crossref","first-page":"F404","DOI":"10.1152\/ajprenal.00126.2010","article-title":"Excess diuresis and natriuresis during acute sleep deprivation in healthy adults","volume":"299","author":"Kamperis","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib110","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-27223-6","article-title":"Relationship between postpartum depression and plasma vasopressin level at 6-8 weeks postpartum: a cross-sectional study","volume":"13","author":"Kashkouli","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.628","article-title":"Hypothalamic-pituitary-adrenal axis and depression symptom effects of an arginine vasopressin type 1B receptor antagonist in a one-week randomized Phase 1b trial","volume":"7","author":"Katz","year":"2017","journal-title":"Brain Behav."},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib112","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1172\/JCI9516","article-title":"Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP","volume":"106","author":"Kaufmann","year":"2000","journal-title":"J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib113","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00726-006-0333-y","article-title":"Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety","volume":"31","author":"Keck","year":"2006","journal-title":"Amino Acids"},{"key":"10.1016\/j.peptides.2024.171166_bib114","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66609","article-title":"Neural basis for regulation of vasopressin secretion by anticipated disturbances in osmolality","volume":"10","author":"Kim","year":"2021","journal-title":"Elife"},{"issue":"9","key":"10.1016\/j.peptides.2024.171166_bib115","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1460-9568.2008.06463.x","article-title":"Synaptic contacts of vesicular glutamate transporter 2 fibres on chemically identified neurons of the hypothalamic suprachiasmatic nucleus of the rat","volume":"28","author":"Kiss","year":"2008","journal-title":"Eur. J. Neurosci."},{"issue":"14","key":"10.1016\/j.peptides.2024.171166_bib116","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMra1404726","article-title":"Molecular physiology of water balance","volume":"372","author":"Knepper","year":"2015","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib117","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1152\/physrev.00035.2011","article-title":"Vasopressin V1a and V1b receptors: from molecules to physiological systems","volume":"92","author":"Koshimizu","year":"2012","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib118","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00005344-199004000-00009","article-title":"V2-like receptors mediate cerebral blood flow increase following vasopressin administration in rats","volume":"15","author":"Ko\u017aniewska","year":"1990","journal-title":"J. Cardiovasc Pharm."},{"issue":"10","key":"10.1016\/j.peptides.2024.171166_bib119","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1210\/endo.139.10.6259","article-title":"Sex differences in the daily rhythm of vasoactive intestinal polypeptide but not arginine vasopressin messenger ribonucleic acid in the suprachiasmatic nuclei","volume":"139","author":"Krajnak","year":"1998","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.peptides.2024.171166_bib120","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1089\/neu.2016.4514","article-title":"Time-Dependent Effects of Arginine-Vasopressin V1 Receptor Inhibition on Secondary Brain Damage after Traumatic Brain Injury","volume":"34","author":"Krieg","year":"2017","journal-title":"J. Neurotrauma"},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib121","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/neu.2013.3274","article-title":"Effect of small molecule vasopressin V1a and V2 receptor antagonists on brain edema formation and secondary brain damage following traumatic brain injury in mice","volume":"32","author":"Krieg","year":"2015","journal-title":"J. Neurotrauma"},{"issue":"5","key":"10.1016\/j.peptides.2024.171166_bib122","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1517\/13543780902889760","article-title":"Lixivaptan: a novel vasopressin receptor antagonist","volume":"18","author":"Ku","year":"2009","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"3-4","key":"10.1016\/j.peptides.2024.171166_bib123","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.yfrne.2004.05.001","article-title":"Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication","volume":"25","author":"Landgraf","year":"2004","journal-title":"Front Neuroendocr."},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib124","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0304-3940(87)90527-1","article-title":"Centrally injected arginine vasopressin (AVP) facilitates social memory in rats","volume":"77","author":"Le Moal","year":"1987","journal-title":"Neurosci. Lett."},{"issue":"11","key":"10.1016\/j.peptides.2024.171166_bib125","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1681\/ASN.2014111067","article-title":"Deep Sequencing in Microdissected Renal Tubules Identifies Nephron Segment-Specific Transcriptomes","volume":"26","author":"Lee","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib126","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00441-018-2899-6","article-title":"Imaging neuropeptide effects on human brain function","volume":"375","author":"Lefevre","year":"2019","journal-title":"Cell Tissue Res"},{"issue":"12","key":"10.1016\/j.peptides.2024.171166_bib127","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1136\/gut.26.12.1385","article-title":"Enhancement of renal function with ornipressin in a patient with decompensated cirrhosis","volume":"26","author":"Lenz","year":"1985","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib128","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.30.1.90","article-title":"Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis","volume":"30","author":"Lenz","year":"1989","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib129","article-title":"Hydrocephalus-Associated Hyponatremia: A Review","volume":"14","author":"Li","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.peptides.2024.171166_bib130","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3214918","article-title":"Effect of Endogenous Arginine-Vasopressin Arising from the Paraventricular Nucleus on Learning and Memory Functions in Vascular Dementia Model Rats","volume":"2017","author":"Li","year":"2017","journal-title":"Biomed. Res Int"},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib131","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/01.CIR.91.1.215","article-title":"Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs","volume":"91","author":"Lindner","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2024.171166_bib132","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/471631","article-title":"Lost Polarization of Aquaporin4 and Dystroglycan in the Core Lesion after Traumatic Brain Injury Suggests Functional Divergence in Evolution","volume":"2015","author":"Liu","year":"2015","journal-title":"Biomed. Res Int"},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib133","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/jnen\/59.4.314","article-title":"Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression","volume":"59","author":"Liu","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"8","key":"10.1016\/j.peptides.2024.171166_bib134","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s10072-012-1233-4","article-title":"Aquaporin-4 distribution in control and stressed astrocytes in culture and in the cerebrospinal fluid of patients with traumatic brain injuries","volume":"34","author":"Lo Pizzo","year":"2013","journal-title":"Neurol. Sci."},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128782","article-title":"Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit","volume":"10","author":"Lopez-Rodriguez","year":"2015","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.peptides.2024.171166_bib136","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.3760\/cma.j.issn.0366-6999.20131139","article-title":"Relationship between AQP4 expression and structural damage to the blood-brain barrier at early stages of traumatic brain injury in rats","volume":"126","author":"Lu","year":"2013","journal-title":"Chin. Med J. (Engl. )"},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib137","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2826.1994.tb00634.x","article-title":"Activation of vasopressin neurons in aging and Alzheimer's disease","volume":"6","author":"Lucassen","year":"1994","journal-title":"J. Neuroendocr."},{"issue":"2-3","key":"10.1016\/j.peptides.2024.171166_bib138","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3940(00)00846-6","article-title":"GABAergic projection from the arcuate nucleus to the supraoptic nucleus in the rat","volume":"281","author":"Ludwig","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.peptides.2024.171166_bib139","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-3-7091-0693-8_32","article-title":"Post-treatment with SR49059 improves outcomes following an intracerebral hemorrhagic stroke in mice","volume":"111","author":"Manaenko","year":"2011","journal-title":"Acta Neurochir. Suppl."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib140","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.neuint.2011.01.018","article-title":"Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury","volume":"58","author":"Manaenko","year":"2011","journal-title":"Neurochem Int"},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib141","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/72256","article-title":"Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke","volume":"6","author":"Manley","year":"2000","journal-title":"Nat. Med"},{"key":"10.1016\/j.peptides.2024.171166_bib142","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainres.2014.06.005","article-title":"Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury","volume":"1581","author":"Marmarou","year":"2014","journal-title":"Brain Res"},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib143","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ana.410200603","article-title":"Vasopressin in Alzheimer's disease: a study of postmortem brain concentrations","volume":"20","author":"Mazurek","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.peptides.2024.171166_bib144","unstructured":"McCarty T.S., Patel P. Desmopressin. [Updated 2023 Jun 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554582\/\u3009."},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1523\/JNEUROSCI.0733-19.2019","article-title":"Revisiting the Stress Concept: Implications for Affective Disorders","volume":"40","author":"McEwen","year":"2020","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.peptides.2024.171166_bib146","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/nn.4086","article-title":"Mechanisms of stress in the brain","volume":"18","author":"McEwen","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib147","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.semnephrol.2006.02.001","article-title":"Water intake and the neural correlates of the consciousness of thirst","volume":"26","author":"McKinley","year":"2006","journal-title":"Semin Nephrol."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib148","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.0953-8194.2004.01184.x","article-title":"Vasopressin secretion: osmotic and hormonal regulation by the lamina terminalis","volume":"16","author":"McKinley","year":"2004","journal-title":"J. Neuroendocr."},{"issue":"9","key":"10.1016\/j.peptides.2024.171166_bib149","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1021\/ja01494a044","article-title":"Preparation of Lysine-vasopressin through a Crystalline Protected Nonapeptide Intermediate and Purification of the Hormone by Chromatography1","volume":"82","author":"Meienhofer","year":"1960","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0404.1994.tb02682.x","article-title":"Plasma concentrations of prolactin, noradrenaline, vasopressin and oxytocin during and after a prolonged epileptic seizure","volume":"90","author":"Meierkord","year":"1994","journal-title":"Acta Neurol. Scand."},{"issue":"16","key":"10.1016\/j.peptides.2024.171166_bib151","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1073\/pnas.0511311103","article-title":"Neural mechanisms of genetic risk for impulsivity and violence in humans","volume":"103","author":"Meyer-Lindenberg","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.peptides.2024.171166_bib152","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.biopsych.2005.12.010","article-title":"Increased arginine vasopressin mRNA expression in the human hypothalamus in depression: A preliminary report","volume":"60","author":"Meynen","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib153","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/0972-5229.83006","article-title":"Vasopressin: Its current role in anesthetic practice","volume":"15","author":"Mitra","year":"2011","journal-title":"Indian J. Crit. Care Med"},{"issue":"9","key":"10.1016\/j.peptides.2024.171166_bib154","doi-asserted-by":"crossref","first-page":"806","DOI":"10.2176\/nmc.29.806","article-title":"Influence of vasopressin level on osmotic pressure and sodium concentration in plasma and cerebrospinal fluid in patients with intracranial lesions","volume":"29","author":"Miura","year":"1989","journal-title":"Neurol. Med Chir. (Tokyo)"},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1034\/j.1600-0722.2003.00050.x","article-title":"Effects of local injection of prilocaine-felypressin on the myocardial oxygen balance in dogs","volume":"111","author":"Miyachi","year":"2003","journal-title":"Eur. J. Oral. Sci."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib156","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0006-3223(00)00886-6","article-title":"Vasopressin, major depression, and hypothalamic-pituitary-adrenocortical desensitization","volume":"48","author":"M\u00fcller","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.peptides.2024.171166_bib157","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/00004647-199811000-00001","article-title":"Matrix metalloproteinases in cerebrovascular disease","volume":"18","author":"Mun-Bryce","year":"1998","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib158","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1530\/eje.0.1300346","article-title":"Secretory pattern of vasopressin in plasma and cerebrospinal fluid of patients with dementia and of two control groups","volume":"130","author":"Nadal","year":"1994","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib159","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/joim.12649","article-title":"Vasopressin and metabolic disorders: translation from experimental models to clinical use","volume":"282","author":"Nakamura","year":"2017","journal-title":"J. Intern Med"},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jpurol.2019.12.020","article-title":"Management and treatment of nocturnal enuresis-an updated standardization document from the International Children's Continence Society","volume":"16","author":"Nev\u00e9us","year":"2020","journal-title":"J. Pedia Urol."},{"key":"10.1016\/j.peptides.2024.171166_bib161","doi-asserted-by":"crossref","DOI":"10.1186\/s13022-015-0017-y","article-title":"Intravenous tranexamic acid as an adjunct haemostat to ornipressin during open myomectomy. A randomized double blind placebo controlled trial","volume":"9","author":"Ngichabe","year":"2015","journal-title":"Ann. Surg. Innov. Res"},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib162","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1152\/physrev.00024.2001","article-title":"Aquaporins in the kidney: from molecules to medicine","volume":"82","author":"Nielsen","year":"2002","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib163","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3233\/JAD-151118","article-title":"Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer's Disease","volume":"52","author":"Nilsson","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.peptides.2024.171166_bib164","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2017.00094","article-title":"Inhibition of Ectopic Arginine Vasopressin Production by Phenytoin in the Small Cell Lung Cancer Cell Line Lu-165","volume":"8","author":"Ohta","year":"2017","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.peptides.2024.171166_bib165","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/978-3-211-85578-2_84","article-title":"The modulation of aquaporin-4 by using PKC-activator (phorbol myristate acetate) and V1a receptor antagonist (SR49059) following middle cerebral artery occlusion\/reperfusion in the rat","volume":"102","author":"Okuno","year":"2008","journal-title":"Acta Neurochir. Suppl."},{"issue":"6435","key":"10.1016\/j.peptides.2024.171166_bib166","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/364341a0","article-title":"Mechanosensitive channels transduce osmosensitivity in supraoptic neurons","volume":"364","author":"Oliet","year":"1993","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib167","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/00365598709180328","article-title":"Aging and urinary vasopressin excretion in healthy men","volume":"21","author":"Os","year":"1987","journal-title":"Scand. J. Urol. Nephrol."},{"key":"10.1016\/j.peptides.2024.171166_bib168","unstructured":"Parsons J.K., Lerner L.B., Barry M.J., Das A.K., Gandhi M.C., Kaplan S.A., et al. Management of benign prostatic hyperplasia\/lower urinary tract symptoms: AUA guideline 2021 [Internet] Linthicum: American Urological Association; 2021. [cited 2022 Jan 13]. Available from: \u3008https:\/\/www.auanet.org\/guidelines-and-quality\/guidelines\/benign-prostatic-hyperplasia-(bph)-guideline\u3009."},{"key":"10.1016\/j.peptides.2024.171166_bib169","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.phrs.2018.01.018","article-title":"Synaptic plasticity modulation by circulating peptides and metaplasticity: Involvement in Alzheimer's disease","volume":"130","author":"Peineau","year":"2018","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00004714-200302000-00007","article-title":"Improvement of sleep and pituitary-adrenal inhibition after subchronic intranasal vasopressin treatment in elderly humans","volume":"23","author":"Perras","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib171","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00004714-199902000-00007","article-title":"Beneficial treatment of age-related sleep disturbances with prolonged intranasal vasopressin","volume":"19","author":"Perras","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib172","doi-asserted-by":"crossref","first-page":"R700","DOI":"10.1152\/ajpregu.00500.2006","article-title":"Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease","volume":"292","author":"Perucca","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib173","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000081314","article-title":"Mineralocorticoid treatment upregulates the hypothalamic vasopressinergic system of spontaneously hypertensive rats","volume":"80","author":"Pietranera","year":"2004","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib174","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12342","article-title":"A Direct Neurokinin B Projection from the Arcuate Nucleus Regulates Magnocellular Vasopressin Cells of the Supraoptic Nucleus","volume":"28","author":"Pineda","year":"2016","journal-title":"J. Neuroendocr."},{"key":"10.1016\/j.peptides.2024.171166_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104419","article-title":"Plasma oxytocin and vasopressin levels in young and older men and women: Functional relationships with attachment and cognition","volume":"110","author":"Plasencia","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"10.1016\/j.peptides.2024.171166_bib176","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0024-3205(92)90368-Y","article-title":"Long-term facilitation of social recognition in rats by vasopressin related peptides: a structure-activity study","volume":"50","author":"Popik","year":"1992","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib177","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00213-015-4187-4","article-title":"Reduced vasopressin receptors activation mediates the anti-depressant effects of fluoxetine and venlafaxine in bulbectomy model of depression","volume":"233","author":"Poretti","year":"2016","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.peptides.2024.171166_bib178","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.744177","article-title":"Vasopressin and Breathing: Review of Evidence for Respiratory Effects of the Antidiuretic Hormone","volume":"12","author":"Proczka","year":"2021","journal-title":"Front Physiol."},{"issue":"12","key":"10.1016\/j.peptides.2024.171166_bib179","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4155\/fmc-2018-0090","article-title":"Advocating for mutually beneficial access to shelved compounds","volume":"10","author":"Pulley","year":"2018","journal-title":"Future Med Chem."},{"key":"10.1016\/j.peptides.2024.171166_bib180","doi-asserted-by":"crossref","DOI":"10.1177\/17562848221098253","article-title":"Practice guidance for the use of terlipressin for liver cirrhosis-related complications","volume":"15","author":"Qi","year":"2022","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib181","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/2278-330X.136811","article-title":"Tolvaptan","volume":"3","author":"Rangarajan","year":"2014","journal-title":"South Asian J. Cancer"},{"issue":"16","key":"10.1016\/j.peptides.2024.171166_bib182","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1089\/neu.2012.2807","article-title":"Arginine vasopressin V1a receptor-deficient mice have reduced brain edema and secondary brain damage following traumatic brain injury","volume":"30","author":"Rauen","year":"2013","journal-title":"J. Neurotrauma"},{"issue":"7","key":"10.1016\/j.peptides.2024.171166_bib183","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/jama.2019.20848","article-title":"Selepressin for Patients With Septic Shock","volume":"323","author":"Rehberg","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.peptides.2024.171166_bib184","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0079-6123(08)61591-5","article-title":"Vasopressin metabolites: a link between vasopressin and memory?","volume":"119","author":"Reijmers","year":"1998","journal-title":"Prog. Brain Res"},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib185","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/jcbfm.2013.30","article-title":"'Hit & Run' model of closed-skull traumatic brain injury (TBI) reveals complex patterns of post-traumatic AQP4 dysregulation","volume":"33","author":"Ren","year":"2013","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"7","key":"10.1016\/j.peptides.2024.171166_bib186","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/jnr.20819","article-title":"Time course of aquaporin expression after transient focal cerebral ischemia in mice","volume":"83","author":"Ribeiro Mde","year":"2006","journal-title":"J. Neurosci. Res"},{"issue":"12","key":"10.1016\/j.peptides.2024.171166_bib187","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1091\/mbc.e04-04-0337","article-title":"Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells","volume":"15","author":"Robben","year":"2004","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.peptides.2024.171166_bib188","first-page":"S20","article-title":"Physiology of ADH secretion","volume":"21","author":"Robertson","year":"1987","journal-title":"Kidney Int Suppl."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib189","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1172\/JCI114804","article-title":"Hyponatremia in rats induces downregulation of vasopressin synthesis","volume":"86","author":"Robinson","year":"1990","journal-title":"J. Clin. Invest"},{"issue":"10","key":"10.1016\/j.peptides.2024.171166_bib190","article-title":"Oxytocin- and arginine vasopressin-containing fibers in the cortex of humans, chimpanzees, and rhesus macaques","volume":"80","author":"Rogers","year":"2018","journal-title":"Am. J. Prima"},{"key":"10.1016\/j.peptides.2024.171166_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2020.104888","article-title":"Vasopressin regulates daily rhythms and circadian clock circuits in a manner influenced by sex","volume":"127","author":"Rohr","year":"2021","journal-title":"Horm. Behav."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib192","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11102-015-0703-0","article-title":"Arginine vasopressin (AVP): a review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system","volume":"19","author":"Rotondo","year":"2016","journal-title":"Pituitary"},{"issue":"12","key":"10.1016\/j.peptides.2024.171166_bib193","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1210\/jc.2014-2295","article-title":"Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease","volume":"99","author":"Roussel","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1-3","key":"10.1016\/j.peptides.2024.171166_bib194","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.schres.2013.01.019","article-title":"Peripheral vasopressin but not oxytocin relates to severity of acute psychosis in women with acutely-ill untreated first-episode psychosis","volume":"146","author":"Rubin","year":"2013","journal-title":"Schizophr. Res"},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib195","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/schbul\/sbu027","article-title":"Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders","volume":"40","author":"Rubin","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib196","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-017-1798-7","article-title":"Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients","volume":"21","author":"Russell","year":"2017","journal-title":"Crit. Care"},{"issue":"28","key":"10.1016\/j.peptides.2024.171166_bib197","doi-asserted-by":"crossref","first-page":"8008","DOI":"10.1002\/anie.201602729","article-title":"A Three-Site Mechanism for Agonist\/Antagonist Selective Binding to Vasopressin Receptors","volume":"55","author":"Saleh","year":"2016","journal-title":"Angew. Chem. Int Ed. Engl."},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib198","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00213-006-0424-1","article-title":"Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats","volume":"187","author":"Salom\u00e9","year":"2006","journal-title":"Psychopharmacol. (Berl. )"},{"issue":"9","key":"10.1016\/j.peptides.2024.171166_bib199","article-title":"Current Classification of Seizures and Epilepsies: Scope, Limitations and Recommendations for Future Action","volume":"12","author":"Sarmast","year":"2020","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib200","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.neuroscience.2004.12.012","article-title":"Environmental light and suprachiasmatic nucleus interact in the regulation of body temperature","volume":"132","author":"Scheer","year":"2005","journal-title":"Neuroscience"},{"issue":"Suppl1","key":"10.1016\/j.peptides.2024.171166_bib201","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.amjmed.2006.05.007","article-title":"Water and sodium retention in edematous disorders: role of vasopressin and aldosterone","volume":"119","author":"Schrier","year":"2006","journal-title":"Am. J. Med"},{"issue":"12","key":"10.1016\/j.peptides.2024.171166_bib202","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/jnnp.51.12.1538","article-title":"Cerebrospinal fluid neurohypophysial peptides in benign intracranial hypertension","volume":"51","author":"Seckl","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.peptides.2024.171166_bib203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1192\/bjp.187.2.101","article-title":"Social defeat: risk factor for schizophrenia?","volume":"187","author":"Selten","year":"2005","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.peptides.2024.171166_bib204","series-title":"Intracranial Hypertension. [Updated 2023 May 8]. In: StatPearls [Internet]","author":"Sharma","year":"2023"},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib205","doi-asserted-by":"crossref","first-page":"63","DOI":"10.17245\/jdapm.2015.15.2.63","article-title":"Advantages of anterior inferior alveolar nerve block with felypressin-propitocaine over conventional epinephrine-lidocaine: an efficacy and safety study","volume":"15","author":"Shinzaki","year":"2015","journal-title":"J. Dent. Anesth. Pain. Med"},{"issue":"12","key":"10.1016\/j.peptides.2024.171166_bib206","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1161\/01.STR.0000039405.31526.06","article-title":"Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model","volume":"33","author":"Shuaib","year":"2002","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib207","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1474-4422(07)70055-8","article-title":"Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications","volume":"6","author":"Simard","year":"2007","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.peptides.2024.171166_bib208","doi-asserted-by":"crossref","first-page":"a022848","DOI":"10.1101\/cshperspect.a022848","article-title":"Epilepsy: A Spectrum Disorder","volume":"5","author":"Sirven","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med"},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib209","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/psc.714","article-title":"Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.","volume":"12","author":"Slusarz","year":"2006","journal-title":"J. Pept. Sci."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib210","doi-asserted-by":"crossref","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress","volume":"8","author":"Smith","year":"2006","journal-title":"Dialog-. Clin. Neurosci."},{"key":"10.1016\/j.peptides.2024.171166_bib211","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.psyneuen.2019.05.010","article-title":"Sleep quality is associated with vasopressin methylation in pregnant and postpartum women with a history of psychosocial stress","volume":"107","author":"Solomonova","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib212","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.neuron.2013.04.025","article-title":"Dendritic peptide release mediates interpopulation crosstalk between neurosecretory and preautonomic networks","volume":"78","author":"Son","year":"2013","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib213","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/jnnp.48.1.50","article-title":"Cerebrospinal fluid vasopressin in neurological and psychiatric disorders","volume":"48","author":"S\u00f8rensen","year":"1985","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/j.peptides.2024.171166_bib214","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/jnnp.46.10.911","article-title":"CSF and plasma vasopressin concentrations in dementia","volume":"46","author":"S\u00f8rensen","year":"1983","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/biomedicines9010089","article-title":"The Biology of Vasopressin","volume":"9","author":"Sparapani","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib216","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.npp.1300562","article-title":"Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415","volume":"30","author":"Stemmelin","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib217","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.physbeh.2007.04.007","article-title":"Presystemic signals in the control of thirst, salt appetite, and vasopressin secretion","volume":"91","author":"Stricker","year":"2007","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib218","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.physbeh.2010.11.019","article-title":"Pre-systemic controls of fluid intake and vasopressin secretion","volume":"103","author":"Stricker","year":"2011","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib219","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/cne.903370210","article-title":"Vasopressin and oxytocin gene expression in the human hypothalamus","volume":"337","author":"Sukhov","year":"1993","journal-title":"J. Comp. Neurol."},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib220","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/jnnp.46.1.14","article-title":"Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases","volume":"46","author":"Sundquist","year":"1983","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib221","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0006-8993(85)91350-2","article-title":"The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia","volume":"342","author":"Swaab","year":"1985","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib222","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2174\/1389200218666170119145900","article-title":"Vasopressin and Related Peptides; Potential Value in Diagnosis, Prognosis and Treatment of Clinical Disorders","volume":"18","author":"Szczepanska-Sadowska","year":"2017","journal-title":"Curr. Drug Metab."},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib223","article-title":"Aldosterone and mineralocorticoid receptors in regulation of the cardiovascular system and pathological remodelling of the heart and arteries","volume":"69","author":"Sztechman","year":"2018","journal-title":"J. Physiol. Pharm."},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib224","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0022-3565(24)36784-9","article-title":"Pharmacological profile of YM087, a novel potent nonpeptide vasopressin V1A and V2 receptor antagonist, in vitro and in vivo","volume":"282","author":"Tahara","year":"1997","journal-title":"J. Pharm. Exp. Ther."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib225","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0091-3057(99)00034-9","article-title":"Effects of arginine-vasopressin fragment 4-9 on rodent cholinergic systems","volume":"63","author":"Tanabe","year":"1999","journal-title":"Pharm. Biochem Behav."},{"issue":"5","key":"10.1016\/j.peptides.2024.171166_bib226","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00125-015-3496-9","article-title":"Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats","volume":"58","author":"Taveau","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2024.171166_bib227","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.pharmtox.41.1.175","article-title":"The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists","volume":"41","author":"Thibonnier","year":"2001","journal-title":"Annu Rev. Pharm. Toxicol."},{"key":"10.1016\/j.peptides.2024.171166_bib228","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0079-6123(08)61568-X","article-title":"Signal transduction pathways of the human V1-vascular, V2-renal, V3-pituitary vasopressin and oxytocin receptors","volume":"119","author":"Thibonnier","year":"1998","journal-title":"Prog. Brain Res"},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib229","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0306-4530(02)00133-6","article-title":"The effects of vasopressin on human facial responses related to social communication","volume":"29","author":"Thompson","year":"2004","journal-title":"Psychoneuroendocrinology"},{"issue":"7287","key":"10.1016\/j.peptides.2024.171166_bib230","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature08826","article-title":"An intrinsic vasopressin system in the olfactory bulb is involved in social recognition","volume":"464","author":"Tobin","year":"2010","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.peptides.2024.171166_bib231","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1089\/neu.2008.0597","article-title":"Role of vasopressin V(1a) and V2 receptors for the development of secondary brain damage after traumatic brain injury in mice","volume":"25","author":"Trabold","year":"2008","journal-title":"J. Neurotrauma"},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib232","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00000542-200609000-00026","article-title":"The vasopressin system: physiology and clinical strategies","volume":"105","author":"Treschan","year":"2006","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib233","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nn.2503","article-title":"Central clock excites vasopressin neurons by waking osmosensory afferents during late sleep","volume":"13","author":"Trudel","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"15","key":"10.1016\/j.peptides.2024.171166_bib234","doi-asserted-by":"crossref","first-page":"PL241","DOI":"10.1016\/0024-3205(94)00424-2","article-title":"Differing effects of vasopressin on regional cerebral blood flow of dogs following intracisternal vs. intra-arterial administration","volume":"54","author":"Tsugane","year":"1994","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib235","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1210\/endo.140.2.6675","article-title":"CRF type I receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammation","volume":"140","author":"Turnbull","year":"1999","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib236","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00421-013-2667-y","article-title":"Blood pressure regulation IX: cerebral autoregulation under blood pressure challenges","volume":"114","author":"Tzeng","year":"2014","journal-title":"Eur. J. Appl. Physiol."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib237","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/WNP.0000000000000377","article-title":"Structure and Function of the Human Insula","volume":"34","author":"Uddin","year":"2017","journal-title":"J. Clin. Neurophysiol."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib238","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neuroscience.2004.06.046","article-title":"Edema and brain trauma","volume":"129","author":"Unterberg","year":"2004","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib239","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0006-3223(97)80433-7","article-title":"Plasma arginine vasopressin and motor activity in major depression","volume":"43","author":"van Londen","year":"1998","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.peptides.2024.171166_bib240","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0889-8537(01)00012-8","article-title":"Cerebral blood flow and vascular physiology","volume":"20","author":"Vavilala","year":"2002","journal-title":"Anesth. Clin. North Am."},{"issue":"5","key":"10.1016\/j.peptides.2024.171166_bib241","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0143-4179(97)90044-5","article-title":"Vasopressin fragment, AVP-(4-8), improves long-term and short-term memory in the hole board search task","volume":"31","author":"Vawter","year":"1997","journal-title":"Neuropeptides"},{"key":"10.1016\/j.peptides.2024.171166_bib242","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0079-6123(08)00422-6","article-title":"Central vasopressin and oxytocin release: regulation of complex social behaviours","volume":"170","author":"Veenema","year":"2008","journal-title":"Prog. Brain Res"},{"issue":"11","key":"10.1016\/j.peptides.2024.171166_bib243","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.psyneuen.2013.06.002","article-title":"Sex-specific modulation of juvenile social play by vasopressin","volume":"38","author":"Veenema","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib244","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1521-690X(03)00049-6","article-title":"Disorders of body water homeostasis","volume":"17","author":"Verbalis","year":"2003","journal-title":"Best. Pr. Res Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.peptides.2024.171166_bib245","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00441-018-2867-1","article-title":"The role of vasopressin in olfactory and visual processing","volume":"375","author":"Wacker","year":"2019","journal-title":"Cell Tissue Res"},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib246","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.yhbeh.2011.08.014","article-title":"Vasopressin, oxytocin, and social odor recognition","volume":"61","author":"Wacker","year":"2012","journal-title":"Horm. Behav."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib247","doi-asserted-by":"crossref","first-page":"E1092","DOI":"10.1152\/ajpendo.00440.2007","article-title":"Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP","volume":"293","author":"Wallis","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2024.171166_bib248","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-020-00623-3","article-title":"Differential diagnostic value of bilateral inferior Petrosal sinus sampling (BIPSS) in ACTH-dependent Cushing syndrome: A systematic review and Meta-analysis","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Endocr. Disord."},{"issue":"7","key":"10.1016\/j.peptides.2024.171166_bib249","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1161\/01.STR.29.7.1462","article-title":"Vasopressin combined with epinephrine decreases cerebral perfusion compared with vasopressin alone during cardiopulmonary resuscitation in pigs","volume":"29","author":"Wenzel","year":"1998","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib250","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/pchj.102","article-title":"The arginine vasopressin V1b receptor gene and prosociality: Mediation role of emotional empathy","volume":"4","author":"Wu","year":"2015","journal-title":"Psych. J."},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib251","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1464-410X.2012.11547.x","article-title":"Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial","volume":"111","author":"Yamaguchi","year":"2013","journal-title":"BJU Int"},{"issue":"Suppl 1","key":"10.1016\/j.peptides.2024.171166_bib252","doi-asserted-by":"crossref","first-page":"113P","DOI":"10.1254\/fpj.114.supplement_113","article-title":"Pharmacology of conivaptan hydrochloride (YM087), a novel vasopressin V1A\/V2 receptor antagonist","volume":"114","author":"Yatsu","year":"1999","journal-title":"Nihon Yakurigaku Zasshi."},{"issue":"12","key":"10.1016\/j.peptides.2024.171166_bib253","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/jcbfm.2009.175","article-title":"Targeted overexpression of endothelin-1 in astrocytes leads to more severe cytotoxic brain edema and higher mortality","volume":"29","author":"Yeung","year":"2009","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.peptides.2024.171166_bib254","first-page":"71","article-title":"Gene regulation system of vasopressin and corticotropin-releasing hormone","volume":"2","author":"Yoshida","year":"2008","journal-title":"Gene Regul. Syst. Bio"},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib255","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000073702","article-title":"Transgenesis and the study of expression, cellular targeting and function of oxytocin, vasopressin and their receptors","volume":"78","author":"Young","year":"2003","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.peptides.2024.171166_bib256","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1135\/cccc19671250","article-title":"Amino acids and peptides. LXXI. Synthesis of 1-deamino-8-D-\u03b3-aminobutyrine-vasopressin, 1-deamino-8-D-lysine-vasopressin, and 1-deamino-8-D-arginine-vasopressin","volume":"32","author":"Zaoral","year":"1967","journal-title":"Collect. Czechoslov. Chem. Commun."},{"issue":"4","key":"10.1016\/j.peptides.2024.171166_bib257","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2174\/187152412803760609","article-title":"Vasopressin in health and disease with a focus on affective disorders","volume":"12","author":"Zelena","year":"2012","journal-title":"Cent. Nerv. Syst. Agents Med Chem."},{"issue":"8","key":"10.1016\/j.peptides.2024.171166_bib258","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136121","article-title":"Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice","volume":"10","author":"Zeynalov","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.peptides.2024.171166_bib259","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.3892\/mmr.2015.4372","article-title":"Expression of aquaporin-4 and pathological characteristics of brain injury in a rat model of traumatic brain injury","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol. Med Rep."},{"issue":"3","key":"10.1016\/j.peptides.2024.171166_bib260","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12264-019-00434-0","article-title":"AVP(4-8) Improves Cognitive Behaviors and Hippocampal Synaptic Plasticity in the APP\/PS1 Mouse Model of Alzheimer's Disease","volume":"36","author":"Zhang","year":"2020","journal-title":"Neurosci. Bull."},{"issue":"8","key":"10.1016\/j.peptides.2024.171166_bib261","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41422-021-00480-2","article-title":"Molecular basis of ligand recognition and activation of human V2 vasopressin receptor","volume":"31","author":"Zhou","year":"2021","journal-title":"Cell Res"},{"issue":"6","key":"10.1016\/j.peptides.2024.171166_bib262","doi-asserted-by":"crossref","first-page":"F521","DOI":"10.1152\/ajprenal.00318.2022","article-title":"Insulin-regulated aminopeptidase is required for water excretion in response to acute hypotonic stress","volume":"324","author":"Zuchowski","year":"2023","journal-title":"Am. J. Physiol. Ren. Physiol."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978124000196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978124000196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:36:51Z","timestamp":1759311411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978124000196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":262,"alternative-id":["S0196978124000196"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2024.171166","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of vasopressin in the treatment of neurological disorders","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2024.171166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"171166"}}